Lyell Immunopharma LYEL
NASDAQ LYEL
$9.26 -0.15 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Sales of Property, Plant and Equipment (2025)

Updated

Lyell Immunopharma (LYEL) posted Sales of Property, Plant and Equipment of $24,000 for Q4 2025, down 90.9% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Sales of Property, Plant and Equipment (2025) Analysis & Trends

For FY2025, Lyell Immunopharma's Sales of Property, Plant and Equipment came in at $287,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lyell Immunopharma 216.66 Mn 216.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24,000.00
Sep 30, 2025 263,000.00
API Access

Lyell Immunopharma Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=LYEL&period=max&api_key=YOUR_API_KEY